Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

for
Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT03310879

Phase 2, Recruiting

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

for
Cancer
Location: Milford DE, Paoli PA, Dover DE, Elk Grove Village IL,
Sponsor: N-Power Medicine

Sex: All

Age: 18 - 70+

Code: NCT06877884

Recruiting

IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)

for
Depression, Depressive Symptoms, Cancer
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06582784

Recruiting

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

for
Breast Cancer Metastatic
Location: New Haven CT, Rochester NY, Atlanta GA
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06750484

Phase 2, Recruiting

Home-Based Physical Activity Intervention for Taxane-Induced CIPN

for
Breast Cancer Female,
Location: Tampa FL
Sponsor: University of South Florida

Sex: Female

Age: 21+

Code: NCT04621721

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

National Mammography Database

for
Breast Cancer Screening and Diagnosis
Location: Reston VA
Sponsor: American College of Radiology

Sex: All

Age: 2 - 70+

Code: NCT01900821

Recruiting

Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart

for
Breast Cancer, Adverse Effect of Radiation Therapy
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: Female

Age: 18 - 70

Code: NCT02052102

Phase 2, Recruiting

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

for
Solid Tumors, Hematologic Malignancies
Location: New York NY, Ann Arbor MI, Nashville TN, Omaha NE,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07195916

Phase 1, Recruiting

Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer

for
Metastatic Breast Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: Female

Age: 60+

Code: NCT06105684

Phase 2, Recruiting

A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors

for
Advanced Solid Tumor, NSCLC
Location: Lafayette IN, San Antonio TX, Spokane WA
Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT05417321

Phase 1, Phase 2, Recruiting

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

for
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 21

Code: NCT04897321

Phase 1, Recruiting

Resilience Mobile App for Teens and Young Adults With Cancer

for
Cancer
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 12 - 25

Code: NCT05842902

Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

for
Breast Cancer, Sarcoma, Gastric Cancer, Lung Cancer,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT06580002

Phase 2, Recruiting

Genetic Information Assistant in Telegenetics

for
Gene Mutation-Related Cancer, Genetic Predisposition
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: All

Age: 18+

Code: NCT06089421

Recruiting

A Study of LM-24C5 For Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Ocala FL
Sponsor: LaNova Medicines Limited

Sex: All

Age: 18+

Code: NCT06187402

Phase 1, Phase 2, Recruiting

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

for
Anal Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm,
Location: New York NY, Baltimore MD, Washington D.C. DC, Miami FL,
Sponsor: AIDS Malignancy Consortium

Sex: All

Age: 18+

Code: NCT05663502

Recruiting

CONFIRM: Magnetic Resonance Guided Radiation Therapy

for
Gastric Cancer, Invasive Breast Cancer, in Situ Breast Cancer,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT04368702

Recruiting

Personalized Oncogenomics (POG) Program of British Columbia

for
Metastatic Cancers, Advanced Cancers,
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18 - 70+

Code: NCT02155621

Recruiting

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

for
Breast Cancer, Cancer of the Breast
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT04968964

Recruiting

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

for
Solid Tumor
Location: Philadelphia PA, Norfolk VA, Pittsburgh PA, Tampa FL,
Sponsor: ImmunoGenesis

Sex: All

Age: 18+

Code: NCT06014502

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial